These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33331727)

  • 1. [The medicinal treatment of COVID-19: a brief update].
    de Boer MGJ; Gieling EM; van der Linden PD; Sinha BNM; Vollaard AM
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current pharmacological treatments for SARS-COV-2: A narrative review.
    Nittari G; Pallotta G; Amenta F; Tayebati SK
    Eur J Pharmacol; 2020 Sep; 882():173328. PubMed ID: 32603692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
    Sanghai N; Shafiq K; Tranmer GK
    Mini Rev Med Chem; 2021; 21(1):3-9. PubMed ID: 32838716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
    Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
    Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
    Choudhury M; Dhanabalan AK; Goswami N
    J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir: A giant step, or a tiptoe?
    Dickinson GM
    Clin Dermatol; 2020; 38(6):773-774. PubMed ID: 32405143
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.
    Szendrey M; Guo J; Li W; Yang T; Zhang S
    J Pharmacol Exp Ther; 2021 May; 377(2):265-272. PubMed ID: 33674391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir: a pendulum in a pandemic.
    Schwartz IS; Heil EL; McCreary EK
    BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523
    [No Abstract]   [Full Text] [Related]  

  • 9. A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.
    Maciorowski D; Idrissi SZE; Gupta Y; Medernach BJ; Burns MB; Becker DP; Durvasula R; Kempaiah P
    SLAS Discov; 2020 Dec; 25(10):1108-1122. PubMed ID: 32942923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientists criticize use of unproven COVID drugs in India.
    Vaidyanathan G
    Nature; 2020 Nov; 587(7833):187-188. PubMed ID: 33169025
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
    Simonis A; Theobald SJ; Fätkenheuer G; Rybniker J; Malin JJ
    EMBO Mol Med; 2021 Jan; 13(1):e13105. PubMed ID: 33015938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
    Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
    Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
    Nili A; Farbod A; Neishabouri A; Mozafarihashjin M; Tavakolpour S; Mahmoudi H
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 33210457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment.
    Chatterjee S
    Drug Res (Stuttg); 2021 Mar; 71(3):138-148. PubMed ID: 33124007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.
    Khazir J; Maqbool T; Mir BA
    Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacodynamics of obeldesivir versus remdesivir.
    Faghihi I; Yan VC
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0096924. PubMed ID: 39133123
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
    Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
    Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
    Dang A; Vallish BN; Dang S
    Indian J Med Ethics; 2020; V(3):202-207. PubMed ID: 33295289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.